InvestorsHub Logo
icon url

brooklyn13

06/11/19 6:21 AM

#48735 RE: nonameface13 #48734

Fine. I think the FDA is a handmaiden to industry, you don't. It's a reasonable disagreement, but history is on my side.
icon url

TTommy

06/11/19 6:56 AM

#48736 RE: nonameface13 #48734

Nice to see an XXII poster who has conviction and faith in their investment. Even though imo Henry and crew have been miserable in moving the company in the right direction.

Unlike some who continually bounce from the devil's advocate to sainthood in the blink of an eye regarding HENRY'S shortcomings over the years being engaged with the FDA. The FDA's inability to protect the citizens of the United States is appalling and should be addressed by the present administration imo.

The FDA has historically been lame causing many deaths from inaction by failing to reign in BIG TOBACCO and BIG PHARMA for decades.

The conviction of this member regarding XXII has deep roots. The present position taken has been due to incompetence on numerous levels on a needlessly long road to projected success by XXII corporate.
icon url

TTommy

06/11/19 7:34 AM

#48737 RE: nonameface13 #48734

What a laugher in moving an agenda! Why would XXII partner with another genetic company to assist in the cannibus, hemp, and tobacco strains if in fact XXII has conveyed to their investors for years they are on point with their I/P PORTFOLIO HELD.

Just another reason why one should be very skeptical of XXII and their botanical genetic modification portfolio. One has to wonder WHY if XXII corporate already had the goods to make it happen. Just maybe that is why BAT dropped Henry and our I/P portfolio agreements.

...using XXII IP of course, will help move the agenda

icon url

2014shelby

06/11/19 8:23 AM

#48740 RE: nonameface13 #48734

Is that in June, by September 23rd (end of summer) or maybe 2020?

Not sure what the hold up is with FDA and hopefully something happens soon